Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Cardiology
•
Cardiovascular Imaging
Would you favor functional or anatomical assessment for CAD in a patient with intermediate CV risk factors with equivocal or nondiagnostic exercise treadmill testing and normal renal function?
Related Questions
What is the role of MRI in assessing the risk of embolism in patients with persistent left ventricular thrombus following myocardial infarction?
What are some practical ways to incorporate cardiac POCUS in the primary care setting?
Would the diagnostic yield for ABIs or peripheral arterial duplex doppler in a patient with metal rods in both legs be similar or acceptable in comparison to those tests in a patient without metal rods?
Would you favor CT AV calcium score or dobutamine stress echo for a patient with symptomatic AS and aortic valve with normal SV/SV index, Vmax 3.4m/s, AVA < 1.0cm2 and mean gradient < 40mmHg?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
What should the LDL target be in patients with prediabetes and high lipoprotein (a) with family history of coronary artery disease?
What class(es) of antihypertensives should be considered next for refractory hypertension in a patient compliant with high doses of Entresto, chlorthalidone, amlodipine, clonidine, and spironolactone if they previously did not have any improvement on beta blocker or hydralazine and work-up for secondary causes were unremarkable?
Do you take any special considerations when working up a pregnant patient for secondary causes of hypertension?
How do you approach caring for patients admitted with decompensated CHF, but who also exhibit hypotension and do not have overt signs of hypervolemia on exam?
What is your risk/benefit analysis when deciding on the appropriateness and timing for discontinuation of systemic anticoagulation in patients who underwent ablation for paroxysmal atrial fibrillation with CHADS2VASc score >2?
